Mobb Deep.
PRODIGE 9 has been released, and maintenance bevacizumab failed to wreak Havoc on subsequent tumor growth among patients with metastatic colorectal cancer who responded well to induction FOLFIRI.
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Comments
Post a Comment